halothane has been researched along with 6-anilino-5,8-quinolinedione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosnjak, ZJ; Eskinder, H; Flynn, N; Hillard, CJ; Kampine, JP | 1 |
| Bina, S; Hart, JL; Jing, M; Ling, GS; Muldoon, SM | 1 |
2 other study(ies) available for halothane and 6-anilino-5,8-quinolinedione
| Article | Year |
|---|---|
Role of guanylate cyclase-cGMP systems in halothane-induced vasodilation in canine cerebral arteries.
Topics: Aminoquinolines; Animals; Cyclic GMP; Dogs; Guanylate Cyclase; Halothane; Muscle, Smooth, Vascular; SRS-A; Vasodilation | 1992 |
Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
Topics: Aminoquinolines; Anesthetics, Inhalation; Animals; Aorta, Thoracic; Binding, Competitive; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Halothane; In Vitro Techniques; Male; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroglycerin; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1998 |